Other languages Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-06 pm EDT			5-day change	1st Jan Change
0.374 ^USD	-1.58%		-30.69%	+37.00%

Apr. 17	Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024	CI
Apr. 17	Brainstorm Cell Therapeutics Inc. Announces Management Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024	Apr. 16
Brainstorm Cell Therapeutics Inc. Announces Management Changes	Apr. 16
Brainstorm Cell Therapeutics Says FDA Agrees on Design of Phase 3B ALS Trial	Apr. 09
BrainStorm Cell Therapeutics Inc. Announces Agreement with FDA on Special Protocol Assessment for Phase 3b Trial in ALS	Apr. 09
Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01
BrainStorm Cell Therapeutics Submits Special Protocol Assessment Request to FDA for Phase 3b Trial of NurOwn in ALS	Feb. 23
Brainstorm Cell Therapeutics Shares Rise on Grants, Allowance of Patent Applications	Dec. 26
Brainstorm Cell Therapeutics Inc. Announces Executive Changes	Dec. 20
BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS	Dec. 07
Brainstorm Cell Says FDA Grants Meeting for Confirmatory Late-Stage Trial for NurOwn in Amyotrophic Lateral Sclerosis	Nov. 20
Brainstorm Cell Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14
Brainstorm Cell Therapeutics Inc. Announces Resignation of Dr. Kirk Taylor as EVP and Chief Medical Officer	23-10-24
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn for the Treatment of ALS	23-10-24
Sector Update: Health Care Stocks Rising in Late Afternoon Trading	23-09-28
Top Midday Decliners	23-09-28
Sector Update: Health Care Stocks Higher in Afternoon Trading	23-09-28
Wall Street Set to Open Flat; Q2 GDP Rises 2.1%; Jobless Claims Lower Than Expected	23-09-28
Sector Update: Health Care Stocks Gain Premarket Thursday	23-09-28
Investors Await GDP, Jobless Claims as US Futures Trend Lower in Thursday's Premarket	23-09-28
Top Premarket Decliners	23-09-28

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Other languages

Filters